BILTRICIDE

This brand name is authorized in United States. It is also authorized in Australia, Canada, Estonia, France, Hong Kong SAR China, Japan, Netherlands, New Zealand, South Africa.

Active ingredients

The drug BILTRICIDE contains one active pharmaceutical ingredient (API):

1	Praziquantel UNII 6490C9U457 - PRAZIQUANTEL
	Praziquantel induces a rapid contraction of schistosomes by a specific effect on the permeability of the cell membrane. The medicine further causes vacuolisation and disintegration of the schistosome tegument.
	Read more about Praziquantel

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
BILTRICIDE Film-coated tablet	MPI, EU: SmPC	Medicines and Medical Devices Safety Authority (NZ)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
P02BA01	Praziquantel	P Antiparasitic products, insecticides and repellents → P02 Anthelmintics → P02B Antitrematodals → P02BA Quinoline derivatives and related substances
Discover more medicines within P02BA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	9447F
CA	Health Products and Food Branch	02230897
EE	Ravimiamet	1187894, 1195714, 1346060, 1346509
FR	Base de données publique des médicaments	60996403
HK	Department of Health Drug Office	25428
JP	医薬品医療機器総合機構	6429006F1039
NL	Z-Index G-Standaard, PRK	23604
NZ	Medicines and Medical Devices Safety Authority	15071
US	FDA, National Drug Code	50419-747
ZA	Health Products Regulatory Authority	P/12/23